Biotech, Pharma and Medical Technology Stock News : OTC stocks, TSX Stocks, NASDAQ and NYSE
Investorideas.com newswire, breaking biotechnology and pharma news
Monday, August 7, 2017
Concussion-focused Scythian (TSXV: $SCYB,V) sets market debut on the TSX Venture Exchange
Concussion-focused Scythian (TSXV: $SCYB.V) sets market debut on the TSX Venture Exchange
The New York City/Toronto-based biotech, led by Great Neck investment banker Jonathan Gilbert on its quest to develop the world’s first pharmaceutical treatment for concussions, will begin trading Aug. 8 on the TSX Venture Exchange, one of Canada’s major stock markets.
Projected to open at $8 (Canadian) per share, Scythian Biosciences (ticker symbol “SCYB”) will float upwards of 2.5 million shares – about half of the company’s outstanding shares, with the rest locked in escrow by the TSX Venture Exchange.
http://www.innovateli.com/concussion-focused-scythian-sets-stock-market-debut/
More Investorideas Biotech Stocks info wwww.BiotechIndustryStocks.com - A Leading Global Investor Website for Biotech Industry Stocks, Biotech, Pharma and Industry News and Biotech Investor Research Tools including a Biotech Stocks Directory Biotech Companies - become a biotech showcase stock on www.investorideas.com and www.biotechindustrystocks.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment